McNeil Supplements Nutritionals Portfolio With Viactiv
This article was originally published in The Tan Sheet
Johnson & Johnson's Viactiv acquisition adds a popular calcium supplement to its nascent McNeil Nutritionals division of niche products.
You may also be interested in...
Johnson & Johnson's appointment of James Lenehan, 53, as president signals a strong commitment by the company to its consumer products segments, despite the firm's shift in emphasis toward its pharmaceutical business over the past ten years
Increased spending on consumer ads and promos for Enfamil infant formula helped the brand post worldwide sales gains of roughly 8% to $172 mil. for the second quarter, Bristol-Myers Squibb's Mead Johnson division said July 25.
American Home Products is interested in the Rx-to-OTC switch possibilities of its proton pump inhibitor Protonix but is unlikely to pursue nonprescription status for the drug in the near-term.